(August 22, 2019) Hackensack, NJ - Hackensack Meridian Health Hackensack University Medical Center announced the implementation of a pilot program to screen cardiology patients for a common, yet often undiagnosed, sleep disorder.
The Department of Sleep Medicine and the Heart and Vascular Hospital have successfully implemented a first of its kind collaborative clinical initiative to screen patients with cardiovascular disease, including Atrial Fibrillation (AFib) - a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications - for Obstructive Sleep Apnea, an involuntary cessation of breathing that occurs while a person is asleep. Using a state-of-the-art home sleep apnea test (HSAT) device called WatchPAT ™. The device tracks the patient’s heart rate, blood oxygen levels, air flow and breathing patterns while the patient is asleep in the comfort of their own home.
“Sleep apnea is very common in patients with Atrial Fibrillation, yet it’s not uniformly diagnosed, in part because it can be a major inconvenience and challenge for patients to stay overnight in a sleep lab at a medical facility,” said David Landers, M.D. vice chair, Heart and Vascular Hospital at Hackensack University Medical Center. “Sleep apnea is directly associated with cardiac disease. Getting treatment for this condition is key.”
The program, which began earlier this year, is being piloted at two cardiology offices. Patients are screened for risk factors, which include having a body mass index (BMI) over 35 and who have been told by a partner that they snore.
“Approximately 22 million adults suffer from sleep apnea, but what’s even more shocking is that 80 percent of these cases are undiagnosed,” said John Villa, D.O., medical director, Institute for Sleep/Wake Disorders at Hackensack University Medical Center. “Sleep apnea is associated with growing health problems including hypertension, cardiac arrhythmias, heart failure and stroke. It can also cause daytime sleepiness, depression, irregular sleep cycles and poor sleep quality.”
Those patients thought to be at high-risk for sleep apnea are given WatchPAT to conduct a sleep test at home. Sleep study data are collected during the test and automatically sent to CloudPAT™ Itamar’s secure server. Once the test is complete, a comprehensive report using WatchPAT’s True Sleep Time, Sleep Architecture and Central Plus algorithms is automatically generated and sent to the prescribing physician.
Pilar Ortiz, an advanced practice nurse (APN) in the Department of Sleep Medicine at Hackensack University Medical Center, screens patients for sleep apnea by asking a series of questions about the patient’s sleep experience, daytime sleepiness and physical characteristics, including weight. This screening tool identifies people who are likely to have sleep apnea or who potentially may develop it, so that once identified, they are given the WatchPAT to take home and become educated on how to use it.
“Patients in the pilot have been diagnosed with various forms of sleep apnea, from mild, to moderate and even severe sleep apnea,” says Pilar Ortiz, APN. “Educating our patients and their families about sleep apnea is crucial. Now that sleep apnea can be more easily detected, through a device patients can wear at home, we can more easily identify those most at risk to help them get the treatment they need.”
“This initiative is the result of innovation and collaboration on the part of our multidisciplinary, clinical teams,” said Mark D. Sparta, FACHE, president and chief hospital executive, Hackensack Meridian Health and executive vice president, Population Health, Hackensack Meridian Health. “I commend the Department of Sleep Medicine and the Heart and Vascular Hospital for their efforts to work together to improve the health and well-being of our patients.”
Once diagnosed, patients are sent to a primary care doctor or a sleep specialist to discuss available treatments. Three potential treatment options include wearing a CPAP, also known as continuous positive airway pressure, which uses mild air pressure to keep a patient’s breathing airway open; wearing an oral appliance to pull the airway forward; or surgery to the upper airway.
“Treating sleep apnea helps the management of the other medical conditions, including the metabolic or cardiac issues from which patients may suffer,” added. Dr. Villa. “Once a patient begins treatment, the side effects caused by sleep apnea begin to improve, including daytime sleepiness.”
“This innovative collaborative program is simultaneously and synergistically treating patients suffering from sleep apnea and cardiovascular disease,” said Michael Horton, administrative director, Clinical Services, Hackensack University Medical Center. “Through this program, we are raising the awareness of cardiac patients that sleep apnea is a common disorder that can be easily diagnosed and treated.”
About Hackensack Meridian Health Hackensack University Medical CenterHackensack Meridian Health Hackensack University Medical Center, a 781-bed nonprofit teaching and research hospital located in Bergen County, NJ, is the largest provider of inpatient and outpatient services in the state. Founded in 1888 as the county’s first hospital, it is now part of the largest, most comprehensive and truly integrated health care network in New Jersey, offering a complete range of medical services, innovative research and life-enhancing care, which is comprised of 34,100 team members and more than 6,500 physicians. Hackensack University Medical Center is ranked #2 in New Jersey and #59 in the country in U.S. News & World Report’s 2019-20 Best Hospital rankings and is ranked high-performing in the U.S. in colon cancer surgery, lung cancer surgery, COPD, heart failure, heart bypass surgery, aortic valve surgery, abdominal aortic aneurysm repair, knee replacement and hip replacement. Out of 4,500 hospitals evaluated, Hackensack is one of only 57 that received a top rating in all nine procedures and conditions. Hackensack University Medical Center is one of only five major academic medical centers in the nation to receive Healthgrades America’s 50 Best Hospitals Award for five or more years in a row. Becker’s Hospital Review recognized Hackensack University Medical Center as one of the 100 Great Hospitals in America 2018. The medical center is one of the top 25 green hospitals in the country according to Practice Greenhealth, and received 26 Gold Seals of Approval™ by The Joint Commission – more than any other hospital in the country. It was the first hospital in New Jersey and second in the nation to become a Magnet® recognized hospital for nursing excellence; receiving its sixth consecutive designation in 2019. Hackensack University Medical Center has created an entire campus of award-winning care, including: John Theurer Cancer Center, a consortium member of the NCI-designated Georgetown Lombardi Comprehensive Cancer Center; the Heart & Vascular Hospital; and the Sarkis and Siran Gabrellian Women’s and Children’s Pavilion, which houses the Joseph M. Sanzari Children’s Hospital and Donna A. Sanzari Women’s Hospital, which was designed with The Deirdre Imus Environmental Health Center® and listed on the Green Guide’s list of Top 10 Green Hospitals in the U.S. Hackensack University Medical Center is the Hometown Hospital of the New York Giants and the New York Red Bulls and is Official Medical Services Provider to THE NORTHERN TRUST PGA Golf Tournament. It remains committed to its community through fundraising and community events especially the Tackle Kids Cancer Campaign providing much needed research at the Children’s Cancer Institute housed at the Joseph M. Sanzari Children’s Hospital. To learn more, visit www.HackensackUMC.org.